The FDA is now approving fewer new drugs than ever before. For life sciences organizations, this means gains have to be generated from other areas, like operations and management efficiencies that cut costs and streamline operations.
Enter electronic lab notebooks (ELNs) with digital signature capability—the modern, paperless method for managing lab-related documents that helps life sciences professionals keep their organizations afloat. With ELNs, scientists can spend more time in the lab rather than wasting time managing paper-based documents. With lab-related documentation in a secure, digital format, life sciences organizations can totally eliminate the costs previously required for backing up, routing, and archiving paper documents. As discussed in a Pharma IQ article, the benefits of ELNs don’t end there. Equipped with digital signature technology, 
ELNs also enable organizations to record proof of innovation quicker than ever with electronic records that will be readable, verifiable, and legally enforceable for decades into the future. Pretty cool, if I may say so myself! Check out the Pharma IQ article to learn more about ELNs and digital signatures.
